Thibault Houles

5PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biologyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 16, 2023
The CDK12 inhibitor SR-4835 functions as a molecular glue that promotes cyclin K degradation in melanoma.

Thibault Houles, Jonathan Boucher, Geneviève Lavoie

|Oct 30, 2022
CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma.

Thibault Houles, Geneviève Lavoie, Sami Nourreddine

|Aug 26, 2022
Multi-Level Control of the ATM/ATR-CHK1 Axis by the Transcription Factor E4F1 in Triple-Negative Breast Cancer.

Kalil Batnini, Thibault Houles, Olivier Kirsh

|Jun 14, 2021
RIOK2 phosphorylation by RSK promotes synthesis of the human small ribosomal subunit.

Emilie L Cerezo, Thibault Houles, Oriane Lié

Pageof 1